Stifel Financial Corp Edwards Lifesciences Corp Transaction History

Stifel Financial Corp

$93.2 Billion
Q3 2024

A detailed history of Stifel Financial Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Stifel Financial Corp holds 232,738 shares of EW stock, worth $17.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

232,738

Previous 208,007 11.89%

Holding current value

$17.3 Million

Previous $19.2 Million 20.06%

% of portfolio

0.02%

Previous 0.02%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$59.7 - $93.78 $1.48 Million - $2.32 Million	24,731 Added 11.89%	232,738 $15.4 Million
Q2 2024 Aug 13, 2024	SELL	$84.3 - $94.31 $331,467 - $370,826	-3,932 Reduced 1.86%	208,007 $19.2 Million
Q1 2024 May 13, 2024	SELL	$72.54 - $95.56 $1.64 Million - $2.15 Million	-22,549 Reduced 9.62%	211,939 $20.3 Million
Q4 2023 Feb 12, 2024	BUY	$61.71 - $77.76 $1.26 Million - $1.59 Million	20,447 Added 9.55%	234,488 $17.9 Million
Q3 2023 Nov 13, 2023	SELL	$69.28 - $93.38 $1.16 Million - $1.56 Million	-16,688 Reduced 7.23%	214,041 $14.8 Million
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $382,138 - $442,785	4,694 Added 2.08%	230,729 $21.8 Million
Q1 2023 May 12, 2023	SELL	$74.26 - $84.51 $9.82 Million - $11.2 Million	-132,237 Reduced 36.91%	226,035 $18.7 Million
Q4 2022 Feb 13, 2023	SELL	$68.3 - $87.44 $6.06 Million - $7.76 Million	-88,706 Reduced 19.85%	358,272 $26.7 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $37,395 - $48,709	454 Added 0.1%	446,978 $36.9 Million
Q2 2022 Aug 15, 2022	BUY	$86.5 - $128.27 $151,202 - $224,215	1,748 Added 0.39%	446,524 $42.5 Million
Q1 2022 May 13, 2022	BUY	$101.96 - $128.34 $7.26 Million - $9.14 Million	71,181 Added 19.05%	444,776 $52.4 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $912,973 - $1.12 Million	-8,583 Reduced 2.25%	373,595 $48.4 Million
Q3 2021 Nov 15, 2021	SELL	$102.91 - $122.75 $689,188 - $822,056	-6,697 Reduced 1.72%	382,178 $43.3 Million
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $2.26 Million - $2.82 Million	-26,928 Reduced 6.48%	388,875 $40.3 Million
Q1 2021 May 14, 2021	SELL	$78.68 - $90.67 $1.1 Million - $1.26 Million	-13,922 Reduced 3.24%	415,803 $34.8 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $3.19 Million - $4.06 Million	44,459 Added 11.54%	429,725 $39.2 Million
Q3 2020 Nov 16, 2020	BUY	$67.19 - $87.44 $3.55 Million - $4.62 Million	52,788 Added 15.88%	385,266 $30.8 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $12.7 Million - $17 Million	220,429 Added 196.73%	332,478 $23 Million
Q1 2020 May 14, 2020	SELL	$52.41 - $81.0 $3.4 Million - $5.26 Million	-64,910 Reduced 36.68%	112,049 $21.2 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $292,894 - $335,337	4,085 Added 2.36%	176,959 $41.3 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $10,463 - $12,823	-170 Reduced 0.1%	172,874 $38 Million
Q2 2019 Aug 14, 2019	BUY	$55.74 - $64.41 $310,304 - $358,570	5,567 Added 3.32%	173,044 $32 Million
Q1 2019 May 14, 2019	BUY	$47.89 - $64.05 $148,794 - $199,003	3,107 Added 1.89%	167,477 $32 Million
Q4 2018 Feb 13, 2019	SELL	$46.41 - $56.94 $104,190 - $127,830	-2,245 Reduced 1.35%	164,370 $25.2 Million
Q3 2018 Nov 13, 2018	BUY	$45.7 - $58.03 $768,445 - $975,774	16,815 Added 11.22%	166,615 $29 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $79,211 - $95,725	1,866 Added 1.26%	149,800 $21.8 Million
Q1 2018 May 11, 2018	BUY	$37.19 - $47.45 $43,698 - $55,753	1,175 Added 0.8%	147,934 $20.6 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $3.22 Million - $3.76 Million	95,400 Added 185.75%	146,759 $16.6 Million
Q3 2017 Nov 13, 2017	BUY	$36.29 - $38.83 $1.86 Million - $1.99 Million	51,359	51,359 $0

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Account

Stifel Financial Corp Edwards Lifesciences Corp Transaction History